Week 24: The Six-Month Milestone
Twenty-four injections. Five dose levels. Six months of changed habits, changed labs, and a changed scale. Week 24 is the largest single checkpoint of the first year — a place to review the data, celebrate the journey, and plan the second half.
In SURMOUNT-1, the 15mg arm averaged approximately 20% mean total body weight reduction by trial endpoint, with the curve at the six-month mark commonly landing in the 18 to 20 percent range. The 10mg arm was a few points behind, the 5mg arm a few points behind that. Real-world cumulative loss at six months tracks below trial averages — most users see 15 to 20 percent at this checkpoint, with significant individual variation.
Six months is also the most established point in the literature where the medication's effect on co-morbidities is well documented. A1C reductions of 1.5 to 2.0 percentage points, meaningful improvements in fasting lipids and blood pressure, and improvements in sleep quality and hepatic markers are all routine at the half-year mark.
Appetite Suppression
Stable near-total at 15mg. The food-noise quiet that defines the journey is now familiar territory rather than a discovery.
Six-month cumulative loss in real-world cohorts commonly lands in this range, with the 15mg arm of SURMOUNT-1 averaging near the top end.
Week 24 Timeline
The Week 24 Timeline
Day 162 (Injection 24)
Fourth 15mg Dose
The 24th injection of the journey. Maximum dose, steady state, predictable rhythm. The weekly cycle is as familiar as it gets.
Days 164-166
Half-Year Review
Compile the full data set: starting and current weight, waist, blood pressure, A1C, lipid panel, liver enzymes, and a clear narrative of dose history and side effect timeline.
Day 168
Plan the Next Six Months
Discuss with your clinician: continue at 15mg, step down to 12.5mg for maintenance, adjust labs cadence, set a goal for month 12. The path forward gets defined here.
What changes by Month 6
Six months of consistent reduced intake, structured eating, and likely some structured movement has reshaped not just the scale but the operating system around food. Smaller meals are normal. Snack drift is largely gone. Social meals do not produce shame spirals or compensatory days. For many users this is the most surprising and welcome change — the relationship with food has changed more than the body has.
Body composition is where the next six months will distinguish themselves. Through month 6, fat loss is the dominant story for most users. Past month 6, the question shifts to how to keep losing what should be lost while protecting what should not be — lean mass, bone density, and metabolic capacity. Strength training and protein become non-negotiable.
The side effect picture at the half-year mark is usually mild or absent. Constipation, occasional reflux, and the rare sulfur burp episode are the most common residual issues. Pancreatitis and gallbladder events remain listed risks, with new or severe abdominal pain warranting prompt evaluation at any point in the journey.
Navigating Symptoms
Six months is the standard checkpoint for a meaningful labs review. A1C, lipid panel, liver enzymes, and basic metabolic panel all routinely improve on tirzepatide and should be tracked.
What other users say
What Users Report
“Six months, down 58 pounds, A1C 5.1, blood pressure down 15 points. The number on the scale is one of the smallest changes — the rest of my health has come along with it.”
— Liana V.
“Half year mark. Lost more than I expected, kept more muscle than I feared, and the food noise is gone. Stepping down to 12.5mg next month for maintenance. Long road still ahead.”
— Roderick S.
Looking ahead
Six months is a launchpad rather than a finish line. The next six months are about consolidation, refinement, and the slow continuation of the trend toward your long-term goal. Continue to the month 6 guide for a deeper half-year review and the framework for what comes next.